General Information of Drug (ID: DMAFUHK)

Drug Name
QGC-001 Drug Info
Synonyms QGC001
Indication
Disease Entry ICD 11 Status REF
Hypertension BA00-BA04 Phase 2 [1]
Cross-matching ID
PubChem CID
24851355
CAS Number
CAS 648927-86-0
TTD Drug ID
DMAFUHK

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
KELATORPHAN DMOX8FD Discovery agent N.A. Investigative [4]
PMID10602705C40 DMLH73O Discovery agent N.A. Investigative [5]
EC33 DM67549 Discovery agent N.A. Investigative [6]
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID1738140C9 DM4BZ2L Discovery agent N.A. Investigative [7]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Aspartyl aminopeptidase (DNPEP) TTGMFY7 DNPEP_HUMAN Inhibitor [2]
Glutamyl aminopeptidase (ENPEP) TT9PBIL AMPE_HUMAN Inhibitor [3]

References

1 ClinicalTrials.gov (NCT02322450) Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of Quantum Genomics.
4 Retro-inverso concept applied to the complete inhibitors of enkephalin-degrading enzymes. J Med Chem. 1988 Sep;31(9):1825-31.
5 Investigation of subsite preferences in aminopeptidase A (EC 3.4.11.7) led to the design of the first highly potent and selective inhibitors of this enzyme. J Med Chem. 1999 Dec 16;42(25):5197-211.
6 Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure. Biochem Soc Trans. 2000;28(4):435-40.
7 Alpha-Keto amide inhibitors of aminopeptidases. J Med Chem. 1992 Feb 7;35(3):451-6.